Delivery Order SPE2D021DA002-SPE2D325F295T
Award Date 8/6/25
Potential Completion Date 8/11/25
Potential Value $2.3K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 27, 2025, for HAVRIX 720 Unit/0.5 ML syringes valued at $2,168.80. This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 28, 2025, with performance to be completed at the awardee's Park Ridge, Illinois location. HAVRIX is a...
- The Defense Logistics Agency (DLA) Medical Supply Chain division awarded a delivery order valued at $2,268.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 10, 2025. The delivery order calls for 1,440 units per milliliter of Havrix, a hepatitis A vaccine, to be delivered by September 15, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- This delivery order, valued at $9,073.60, was awarded on August 4, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of HAVRIX 1,440 unit/mL syringes. The award represents a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and was funded by the Defense Logistics Agency's Medical Supply Chain division. This contract carries no set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price purchase order valued at $1,731.12 for Hepatitis A Virus V on August 11, 2025, with an ultimate completion date of August 26, 2025. The contract was funded by the Medical Supply Chain, a Defense agency component, with performance to be executed in Park Ridge, Illinois. This award carries no set-aside designation and represents a delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,454.93 on August 11, 2025, for the supply of Twinrix vaccine syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense...
- DMS Pharmaceutical Group Inc. was awarded an $813 firm fixed price delivery order against the Defense Logistics Agency's Pharmaceutical Prime Vendor contract to supply 1,440 unit/mL syringes of HAVRIX, a hepatitis A vaccine. Performance will take place in Park Ridge, Illinois with all supplies delivered by February 6, 2023. No set-aside provisions were applied to this order for pharmaceutical products stocked under the Agency's prime vendor program, which leverages commercial distributors to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,233.20 for Hepatitis B Virus vaccine by the Defense Logistics Agency (DLA), operating under the Medical Supply Chain function. This delivery order, issued on August 7, 2025, with an ultimate completion date of the same day, represents a task order issued under DMS Pharmaceutical Group's larger single-award Indefinite...
- DMS Pharmaceutical Group Inc. has been awarded a four hundred six dollar firm fixed price delivery order against an unidentified contract vehicle to supply 1,440 unit/ml syringes of HAVRIX, a vaccine, for use by the Defense Logistics Agency. Performance will take place in Park Ridge, Illinois, with all supplies delivered by February 6, 2023. No set-aside provisions were applied to this order. As the DLA supports military readiness by procuring and providing nearly 100% of the consumable items...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 on July 24, 2025, for the supply of Twinrix vaccine syringes. The order, with an ultimate completion date of July 29, 2025, was issued under a firm fixed-price contract type with no set-aside designation. The place of performance is Park Ridge, Illinois, and the award was funded by the Defense Logistics Agency's Medical Supply Chain...
- The U.S. Defense Logistics Agency awarded a $1,591.88 firm fixed-price purchase order to DMS Pharmaceutical Group Inc. for Hepatitis A Virus vaccine on September 15, 2025, with an ultimate completion date of October 15, 2025. The order will be delivered to Park Ridge, Illinois, where the vendor is based. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected without a set-aside designation. The company maintains a significant Indefinite Delivery...